Suberoylanilide Hydroxamic Acid as a Potential Therapeutic Agent for Human Breast Cancer Treatment

被引:0
作者
Lili Huang
Arthur B. Pardee
机构
[1] Dana-Farber Cancer Institute,Division of Cancer Biology
[2] Harvard Medical School,Department of Biological Chemistry and Molecular Pharmacology
来源
Molecular Medicine | 2000年 / 6卷
关键词
Suberoylanilide Hydroxamic Acid; Apoptosis-regulating Proteins; Gelsolin; Hybrid Polar Compounds (HPCs); Hematopoietic Tumor Cells;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:849 / 866
页数:17
相关论文
共 309 条
  • [11] Russo P(1998)A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases Proc. Natl. Acad. Sci. U.S.A. 95 3003-3007
  • [12] Venta PG(1990)Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A J. Biol. Chem. 265 17174-17179
  • [13] Cordon CC(1999)Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors Nature 401 188-193
  • [14] Rifkind RA(1998)Histone acetylation and transcriptional regulatory mechanisms Genes Dev. 12 599-606
  • [15] Marks PA(1997)Transcriptional control. Sinful repression Nature 387 16-17
  • [16] Siegel DS(1997)What’s up and down with histone deacetylation and transcription? Cell 89 325-328
  • [17] Zhang X(1998)Co-activators and co-repressors in the integration of transcriptional responses Curr. Opin. Cell Biol. 10 373-383
  • [18] Feinman R(1998)Retinoblastoma protein represses transcription by recruiting a histone deacetylase Nature 391 601-605
  • [19] Andreeff M(1998)Retinoblastoma protein recruits histone deacetylase to repress transcription Nature 391 597-601
  • [20] Stone R(1997)Histone deacetylase activity is required for full transcriptional repression by mSin3A Cell 89 341-347